Tirzep
Product Description
Tirzepatide (tirzepatide / tisepatide, trade names Mounjaro, Zepbound / Mufengda) is the world's first GIP/GLP-1 dual receptor agonist, developed by Eli Lilly. It is mainly used for glycemic control in type 2 diabetes and weight loss in obesity or overweight individuals, and is a prescription drug for subcutaneous injection once a week
¡°Strength builds the foundation, and excellent services reach all over the world.¡±
create win-win situation with customers
We have cooperated with experienced shipping forwarders for many years, they arrange the shipment. No matter by express, by air or by sea, we will track the course of the goods all the way, to make sure goods arrive at you on time and in good condition.


